Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (1418)	10/15/1998 2:55:00 AM
From: Rick Strange	Read Replies (2) \| Respond to of 1491

Arriella, seems to me that neither an inhaler or a pill is a suitable vehicle to administer a drug for a patient in a coma that may also be on recessitation. Like you, I'd like an M.D.'s comments. This brings up an interesting point. I ran a search, using a search engine for print media news items, on head trauma and head injury. 90 percent of the items were about Football or Hockey players on the injured list because of head injury. Assuming that HU-211 is ultimately approved for sever head trauma. I wonder what the medical benefit of HU-211 might be for slight or mild head trauma where the patient might not require hospitalization. In this situation, a pill would be quite an asset.